- call +1-201-465-4211
- email sales@mrinsights.biz
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.
Scope of the Report:
During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
The global Tumor Marker Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tumor Marker Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Tumor Marker Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tumor Marker Testing market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott Diagnostics
Affymetrix
Agilent Technologies
Beckman，Dickinson（BD）
BioCurex
BioModa
Clarient
Correlogic Systems
Epigenomics
Hologic
Roche Diagnostics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Biochemical Markers
Oncogenes
Growth Factors
Hormones
Colony Stimulating Factors
Lymphokines
Immunohistochemical Stains
Others
Market Segment by Applications, can be divided into
Hospitals
Commercial/Private Laboratories
Physician Offices/Group Practices
Cancer Clinics
Ambulatory Care Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Tumor Marker Testing Market Overview
1.1 Product Overview and Scope of Tumor Marker Testing
1.2 Classification of Tumor Marker Testing by Types
1.2.1 Global Tumor Marker Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Tumor Marker Testing Revenue Market Share by Types in 2017
1.2.3 Biochemical Markers
1.2.4 Oncogenes
1.2.5 Growth Factors
1.2.6 Hormones
1.2.7 Colony Stimulating Factors
1.2.8 Lymphokines
1.2.9 Immunohistochemical Stains
1.2.10 Others
1.3 Global Tumor Marker Testing Market by Application
1.3.1 Global Tumor Marker Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Commercial/Private Laboratories
1.3.4 Physician Offices/Group Practices
1.3.5 Cancer Clinics
1.3.6 Ambulatory Care Centers
1.4 Global Tumor Marker Testing Market by Regions
1.4.1 Global Tumor Marker Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Tumor Marker Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Tumor Marker Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tumor Marker Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Tumor Marker Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tumor Marker Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Tumor Marker Testing (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Diagnostics
2.1.1 Business Overview
2.1.2 Tumor Marker Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Diagnostics Tumor Marker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Affymetrix
2.2.1 Business Overview
2.2.2 Tumor Marker Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Affymetrix Tumor Marker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Agilent Technologies
2.3.1 Business Overview
2.3.2 Tumor Marker Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Agilent Technologies Tumor Marker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Beckman，Dickinson（BD）
2.4.1 Business Overview
2.4.2 Tumor Marker Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Beckman，Dickinson（BD） Tumor Marker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 BioCurex
2.5.1 Business Overview
2.5.2 Tumor Marker Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BioCurex Tumor Marker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 BioModa
2.6.1 Business Overview
2.6.2 Tumor Marker Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BioModa Tumor Marker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Clarient
2.7.1 Business Overview
2.7.2 Tumor Marker Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Clarient Tumor Marker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Correlogic Systems
2.8.1 Business Overview
2.8.2 Tumor Marker Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Correlogic Systems Tumor Marker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Epigenomics
2.9.1 Business Overview
2.9.2 Tumor Marker Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Epigenomics Tumor Marker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Hologic
2.10.1 Business Overview
2.10.2 Tumor Marker Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Hologic Tumor Marker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.11 Roche Diagnostics
2.11.1 Business Overview
2.11.2 Tumor Marker Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Roche Diagnostics Tumor Marker Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Tumor Marker Testing Market Competition, by Players
3.1 Global Tumor Marker Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Tumor Marker Testing Players Market Share
3.2.2 Top 10 Tumor Marker Testing Players Market Share
3.3 Market Competition Trend
4 Global Tumor Marker Testing Market Size by Regions
4.1 Global Tumor Marker Testing Revenue and Market Share by Regions
4.2 North America Tumor Marker Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Tumor Marker Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Tumor Marker Testing Revenue and Growth Rate (2013-2018)
4.5 South America Tumor Marker Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Tumor Marker Testing Revenue and Growth Rate (2013-2018)
5 North America Tumor Marker Testing Revenue by Countries
5.1 North America Tumor Marker Testing Revenue by Countries (2013-2018)
5.2 USA Tumor Marker Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Tumor Marker Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Tumor Marker Testing Revenue and Growth Rate (2013-2018)
6 Europe Tumor Marker Testing Revenue by Countries
6.1 Europe Tumor Marker Testing Revenue by Countries (2013-2018)
6.2 Germany Tumor Marker Testing Revenue and Growth Rate (2013-2018)
6.3 UK Tumor Marker Testing Revenue and Growth Rate (2013-2018)
6.4 France Tumor Marker Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Tumor Marker Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Tumor Marker Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Tumor Marker Testing Revenue by Countries
7.1 Asia-Pacific Tumor Marker Testing Revenue by Countries (2013-2018)
7.2 China Tumor Marker Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Tumor Marker Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Tumor Marker Testing Revenue and Growth Rate (2013-2018)
7.5 India Tumor Marker Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Tumor Marker Testing Revenue and Growth Rate (2013-2018)
8 South America Tumor Marker Testing Revenue by Countries
8.1 South America Tumor Marker Testing Revenue by Countries (2013-2018)
8.2 Brazil Tumor Marker Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Tumor Marker Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Tumor Marker Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Tumor Marker Testing by Countries
9.1 Middle East and Africa Tumor Marker Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Tumor Marker Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Tumor Marker Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Tumor Marker Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Tumor Marker Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Tumor Marker Testing Revenue and Growth Rate (2013-2018)
10 Global Tumor Marker Testing Market Segment by Type
10.1 Global Tumor Marker Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Tumor Marker Testing Market Forecast by Type (2018-2023)
10.3 Biochemical Markers Revenue Growth Rate (2013-2023)
10.4 Oncogenes Revenue Growth Rate (2013-2023)
10.5 Growth Factors Revenue Growth Rate (2013-2023)
10.6 Hormones Revenue Growth Rate (2013-2023)
10.7 Colony Stimulating Factors Revenue Growth Rate (2013-2023)
10.8 Lymphokines Revenue Growth Rate (2013-2023)
10.9 Immunohistochemical Stains Revenue Growth Rate (2013-2023)
10.10 Others Revenue Growth Rate (2013-2023)
11 Global Tumor Marker Testing Market Segment by Application
11.1 Global Tumor Marker Testing Revenue Market Share by Application (2013-2018)
11.2 Tumor Marker Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Commercial/Private Laboratories Revenue Growth (2013-2018)
11.5 Physician Offices/Group Practices Revenue Growth (2013-2018)
11.6 Cancer Clinics Revenue Growth (2013-2018)
11.7 Ambulatory Care Centers Revenue Growth (2013-2018)
12 Global Tumor Marker Testing Market Size Forecast (2018-2023)
12.1 Global Tumor Marker Testing Market Size Forecast (2018-2023)
12.2 Global Tumor Marker Testing Market Forecast by Regions (2018-2023)
12.3 North America Tumor Marker Testing Revenue Market Forecast (2018-2023)
12.4 Europe Tumor Marker Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Tumor Marker Testing Revenue Market Forecast (2018-2023)
12.6 South America Tumor Marker Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Tumor Marker Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Tumor Marker Testing Picture
Table Product Specifications of Tumor Marker Testing
Table Global Tumor Marker Testing and Revenue (Million USD) Market Split by Product
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
